Skip to main content
Peter Allen, MD, Oncology, Durham, NC

Peter J Allen MD

Gastrointestinal Cancer


Professor of Surgery Chief, Surgical Oncology Duke University Health

Join to View Full Profile
  • Room 475, MSRB-1203 Research DriveDurham, NC 27710

  • Phone+1 919-613-1474

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Capital Consortium
    National Capital ConsortiumResidency, Surgery, 1993 - 1999
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1993

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2001 - 2020
  • DC State Medical License
    DC State Medical License 1995 - 2000
  • Surgery
    American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases  
    Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Press Mentions

  • Understanding and Treating Pancreatic Cancer Cachexia
    Understanding and Treating Pancreatic Cancer CachexiaNovember 14th, 2024
  • Biomarkers Identified to Help Predict Risk of Pancreatic Cyst Progression to Cancer
    Biomarkers Identified to Help Predict Risk of Pancreatic Cyst Progression to CancerMarch 21st, 2023
  • New Biomarkers Could Be “More Accurate” Predictors of Pancreatic Cancer
    New Biomarkers Could Be “More Accurate” Predictors of Pancreatic CancerMarch 20th, 2023
  • Join now to see all

Grant Support

  • Duke Research Training Program in Surgical OncologyDUKE UNIVERSITY2024–2029
  • Duke Research Training Program in Surgical OncologyDUKE UNIVERSITY2024–2029
  • Biomarker validation for intraductal papillary mucinous neoplasms of the pancreasDUKE UNIVERSITY2014–2028
  • Biomarker validation for intraductal papillary mucinous neoplasms of the pancreasDUKE UNIVERSITY2014–2028
  • Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)DUKE UNIVERSITY2019–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: